Provider review · Ranked #6
Hims & Hers review
Large portfolio, no flat-rate structure
Where it wins
- Huge platform with fast access
- Both compounded and brand routes
Trade-offs
- No flat-rate pricing
- Generalist rather than GLP-1-specialized
Pillar-by-pillar scorecard
Clinical Protocol & Named Medical Director15/20
Pharmacy Traceability & Certificate of Analysis13/20
Real-World Cohort Outcomes & Adverse-Event Disclosure14/20
All-Inclusive Flat Pricing9/15
Lab Integration & Longitudinal Follow-Up14/15
Regulatory Clarity10/10